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RESEARCH ARTICLE
Influenza D virus M2 protein exhibits ion
channel activity in Xenopus laevis oocytes
Evan Kesinger, Jianing Liu, Aaron Jensen, Catherine P. Chia, Andrew Demers,
Hideaki Moriyama*




A new type of influenza virus, known as type D, has recently been identified in cattle and
pigs. Influenza D virus infection in cattle is typically asymptomatic; however, its infection in
swine can result in clinical disease. Swine can also be infected with all other types of influ-
enza viruses, namely A, B, and C. Consequently, swine can serve as a “mixing vessel” for
highly pathogenic influenza viruses, including those with zoonotic potential. Currently, the
only antiviral drug available targets influenza M2 protein ion channel is not completely effec-
tive. Thus, it is necessary to develop an M2 ion channel blocker capable of suppressing the
induction of resistance to the genetic shift. To provide a basis for developing novel ion chan-
nel-blocking compounds, we investigated the properties of influenza D virus M2 protein
(DM2) as a drug target.
Results
To test the ion channel activity of DM2, the DNA corresponding to DM2 with cMyc-tag conju-
gated to its carboxyl end was cloned into the shuttle vector pNCB1. The mRNA of the DM2–
cMyc gene was synthesized and injected into Xenopus oocytes. The translation products of
DM2–cMyc mRNA were confirmed by immunofluorescence and mass spectrometry analy-
ses. The DM2–cMyc mRNA-injected oocytes were subjected to the two-electrode voltage-
clamp (TEVC) method, and the induced inward current was observed. The midpoint (Vmid)
values in Boltzmann modeling for oocytes injected with DM2–cMyc RNA or a buffer were
−152 and −200 mV, respectively. Assuming the same expression level in the Xenopus
oocytes, DM2 without tag and influenza C virus M2 protein (CM2) were subjected to the
TEVC method. DM2 exhibited ion channel activity under the condition that CM2 ion channel
activity was reproduced. The gating voltages represented by Vmid for CM2 and DM2 were –
141 and –146 mV, respectively. The reversal potentials observed in ND96 for CM2 and
DM2 were −21 and −22 mV, respectively. Compared with intact DM2, DM2 variants with
mutation in the YxxxK motif, namely Y72A and K76A DM2, showed lower Vmid values while
showing no change in reversal potential.
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The M2 protein from newly isolated influenza D virus showed ion channel activity similar to
that of CM2. The gating voltage was shown to be affected by the YxxxK motif and by the
hydrophobicity and bulkiness of the carboxyl end of the molecule.
Introduction
Influenza virus can infect various animal species, including humans [1, 2]. Although most
influenza virus infections result in mild disease, genetic shift, drift, and reassortment events
have been shown to result in highly pathogenic strains [3]. To date, four influenza virus species
have been identified, namely A, B, C, and D [2, 4]. Type A infects several species, including
humans as well as porcine, bovine, and canine species [5]. Types B and C infect humans and
pigs [6]. Type D is a relatively newly identified type of influenza virus, which has been found
to infect cattle and pigs [4]; it was recognized as a new virus type by the International Commit-
tee of Taxonomy in 2016 (talk.ictvonline.org).
Influenza D virus infection in cattle is typically asymptomatic [7, 8]. However, its infection
in swine can result in clinical disease. Swine can also be infected with all other types of influ-
enza viruses (types A—C). Consequently, swine can serve as a “mixing vessel” for highly
pathogenic influenza viruses, including those with zoonotic potential [9]. A recent study has
confirmed that people working in close proximity to calves have higher rates of seropositivity
to the influenza virus (94%) than the general population (1.3%) [10].
Administration of an efficacious vaccine is most effective in prevention of Influenza infec-
tion achieved [13, 14]. However, if infection has already occurred, the only treatment option is
the use of antivirals. Unfortunately, owing to the inherent instability and high mutation rate of
influenza genomes, most current antivirals are no longer effective at inhibiting influenza virus
replication. The only currently available antiviral that targets the influenza AM2 protein ion
channel (M2; Fig 1) [15, 16], called amantadine (PubChem CID, 2130), is only partially effec-
tive. Thus, there is an urgent need to develop an M2 ion channel blocker capable of suppress-
ing the induction of resistance.
The influenza A virus M2 protein (AM2) is involved in the release of viral RNPs from the
endosome (uncoating) and the transport of hemagglutinin to the cell surface via the trans-
Golgi network [17–19]. In both processes, acidification of the external environment around
the virus activates the M2 proton channel capability, leading to virus disassembly.
The crystal structure of AM2 transmembrane helix has been solved at high resolution (PDB
ID, 4QKL, deposited in monomer format) [20]. Based on this model, electrophysiological
behaviors of the pH-gated M2 proton channel were explained by simulations [21]. Specifically,
Val27 and Ser31 in the amino terminal and His37 and Trp41 in the carboxyl terminal were
shown to act as a hinge and a gate, respectively (referred to as the HxxxW motif hereafter)
[22]. Solid state NMR structures of the channel domain of M2 (2L0J; deposited in tetramer for-
mat; Fig 2) [23] were also reported.
The influenza B virus M2 protein (BM2) also contains the HxxxW motif [22], and the pro-
tein structure in micelle was solved by solution state NMR (2KIX; deposited in tetramer for-
mat) [24].
The influenza C virus M2 protein (CM2) was reported by Hongo et al. [25] [(C/Yamagata/1/
1988); Fig 1], and it was identified to function as a voltage activated chloride ion channel [26].
Although CM2 does not contain the HxxxW motif, the helical region contains a YxxxK motif,
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as revealed by our visual observations (Figs 1 and 2). CM2 undergoes a proteolytic naturaliza-
tion process that removes the leading 24 amino acids [27]. Mature CM2 comprises an amino-
terminal extracellular domain, transmembrane domain, and a carboxyl-terminal internal
domain [27, 28]. In a different isolate, (C/Ann Arbor/1/1950) [29], a transmembrane domain
(Tyr27–Val46) was predicted by site-specific infrared dichroism analysis and a global molecular
dynamics search [12]. Side chains of L31, L34, M41, and L44 residues were predicted to
point to the center of the tetramer assembly. CM2 undergoes oligomerization by disulfide
bonding among Cys1–Cys6–Cys20 [30]. CM2 undergoes glycosylation at Asn11 [27, 28] and
Fig 1. Amino acid sequences. A. Primary structures of influenza C virus M2 protein (CM2; Sequence ID, YP_089658.1 (C/Ann Arbor/1/1950)) and influenza D virus
M2 protein (DM2; AFJ19025 (D/Swine/Oklahoma/1334/2011)). CM2 contains a 24-amino acid signal sequence (−24 to −1). Mature CM2 starts with Cys1 and
contains extracellular, transmembrane (underlined), and internal domains in order from the amino to carboxyl terminals. Amino acid substitutions between
Yamagata [BAA03793.1 (C/Yamagata/1/1988)] and Ann Arbor isolates are indicated in brackets. CM2 has disulfide-linked oligomerization sites (“”; Cys1, Cys6,
Cys20), a glycosylation site (Asn11, “g”), and a palmitoylation site (Cys65, “p”). A phosphorylation site involved in efficient virus replication is also indicated (Ser68,
“k”) [11]. In DM2, the predicted transmembrane domain is indicated by an underline. The YxxxK motif, Tyr72, and Lys76 in D is indicated by bold face. DM2 has a
potential glycosylation site at Asn39 indicated by “g”. A C-terminal variant in D cMyc has a spacer GAG and a cMyc-tag EQKLISEEDL. A readthrough C-terminal
variant of DM2, DM2 RT, has an extra peptide from the vector pNCB1. B. Structures of M2 proteins. AM2. The NMR structure (residues 22–62; PDB ID, 2L0J) and
crystallographic structure (21–46; 4QKL) of influenza A virus M2 protein [AAA43303 [A/Udorn/1972(H3N2)]]. BM2. The NMR structure (1–33; 2KIX) of influenza B
virus M2 protein [ACF54325.1 (B/Taiwan/70061/2006)]. CM2. The structure of influenza C virus M2 protein (27–46) was obtained by site-specific infrared dichroism
[12]. DM2. Influenza D virus M2 protein is focused on in this study. Solved or predicted structures are underlined. Amino acid residues providing experimental
structure information are indicated by underlines. Primary structures of mutated DM2 are added with the isoelectric point (pI) and the hydrophobicity value
(GRAVY) for the shaded helix domain. In GRAVY, greater positive values indicate higher hydrophobicity. C. Predicted secondary structure of carboxyl ends in DM2
constructs. Predicted secondary structures E and H correspond to β-strand and α-helix, respectively.
https://doi.org/10.1371/journal.pone.0199227.g001
IDV M2
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palmitoylation at Cys65 [31]. Three amino acid substitutions that differ between Yamagata and
Ann Arbor isolates were found to be located outside the transmembrane domains.
The type D proteome (D/Swine/Oklahoma/1334/2011), including the M2 protein, shares
more sequence similarity with type C proteome than with type A or B proteome [7]. As such,
many of our inferences about the structure and function of the DM2 protein are derived from
what we know about CM2. We hypothesized that DM2 has voltage-gated chloride ion channel
activity similar to that of CM2 and that this channel might depend on the YxxxK motif present
in both channels (Figs 1 and 2c). To test the hypothesis, we used the two-electrode voltage-
clamp (TEVC) technique coupled with a heterologous expression system with Xenopus oocytes
because this system is well established.
Results
Expression of DM2 protein in Xenopus oocytes
A DM2 construct with a cMyc-tag at its carboxyl end was used to express DM2 in a X. laevis
oocyte (Fig 1). The cMyc-tagged DM2 was expressed under the Xenopus β-globin 50-UTR in
Fig 2. 3D structure of M2 protein. A. The structure of AM2 was solved experimentally by nuclear magnetic resonance spectroscopy (NMR; structures were deposited
in the Protein Data Bank with ID code 2L0J; model 1 is shown while the NMR structure contains 8 isomers). AM2 adopts a homo-tetramer configuration, and the
middle of the assembly contains a pore. The valve residues His37 and Trp41 face inward within the pore on each monomer. B. The monomer structure of AM2 with
valve residues, which control ion flow by pseudo-cation—pi interaction. C. A theoretical model of DM2 in monomer format.
https://doi.org/10.1371/journal.pone.0199227.g002
IDV M2
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the pNCB1 vector, which was adapted from pGEMHE [32]. In vitro transcribed mRNA was
injected into the oocyte, followed by incubation in ND96 medium at 18˚C for 5 days to maxi-
mize protein accumulation. An oocyte injected with phosphate-buffered saline (PBA), fol-
lowed by incubation in ND96 medium at 18˚C for 5 days, was considered as the control.
The injected oocytes were stained to detect the DM2 protein through a cMyc epitope-tag using
primary 9E10 antibody and secondary Alexa Fluor 488 antibody. The stained oocytes were
observed by confocal microscopy (Fig 3). A concentric green layer was observed in the oocyte
injected with RNA encoding cMyc-tagged DM2, whereas the control oocyte showed no fluo-
rescence. This result seemed to be consistent with the observation of CM2 by Hongo et al.
[25], although they used rabbit immune serum against a GST fusion protein containing CM2.
Our results indicated that cMyc-tagged DM2 was produced in the Xenopus oocyte upon the
injection of its RNA and formed a layer near the oocyte surface.
To confirm the expression of DM2–cMyc protein, a tryptic mass spectrometry [33] was
performed on oocytes incubated for 2 days after injection. A peptide of 36-amino acid long
was identified, Arg123—Lys158, which included the carboxyl terminal of DM2, the spacer,
and a portion of the cMyc-tag (Figs 1 and 4; S1 Table). In addition, the expression of
DM2-cMyc protein was confirmed by Western blot analysis (Fig 5). Uninjected and
DM2-cMyc RNA injected oocytes were used, and unique bands were found in the DM2-cMyc
sample. The estimated molecular weights of the lower and upper bands were 20 and 23 kDa,
respectively. The lower band corresponded to the predicted mass of the DM2-cMyc protein,
18304. A potential reason for the additional mass in this experiment was glycosylation at
Asn39 (Fig 1). Modeling predicted this part of the polypeptide to be on the outside of the
oocyte, because Asn39 was located in the leading amino terminus of the transmembrane helix
in the model (Fig 2). When 6 oocytes were used in the preparation, stronger multiple bands
were observed in the DM2-cMyc sample between 25 and 75 kDa. Aggregation, glycosylation
and proteolysis may have been the cause of the multiple bands.
Fig 3. Confocal microscopy of oocytes. A. An oocyte injected with phosphate-buffered saline. B. An oocyte injected with RNA encoding c-Myc-tagged DM2. Oocytes
were treated with anti-cMyc antibodies (mouse 9E10) and then donkey anti-mouse Alexa Fluor 488 antibodies.
https://doi.org/10.1371/journal.pone.0199227.g003
IDV M2
PLOS ONE | https://doi.org/10.1371/journal.pone.0199227 June 21, 2018 5 / 16
DM2 was considered to have been sorted into the plasma membrane, as in the case for the
AM2 and the CM2, whereas the carboxyl-terminus cMyc-tag was assumed to be in the cytosol.
The fragment that we identified may have arisen because the DM2–cMyc protein was not pro-
tected from the membrane disruption due to the trypsin treatment. Nevertheless, the observa-
tion by microscopy was supported by the results obtained by the mass spectrometry and the
Western blot.
Ion channel activities for DM2 protein
A defolliculated Xenopus oocyte and an oocyte injected with PBS were subjected to the TEVC
method after 2 days of incubation (Fig 5). Both oocytes exhibited an inward current of approx-
imately −5 μA when the membrane voltage was maintained at −200 mV (Fig 6A and 6B). The
behaviors of intact and PBS-injected oocytes were similar, and the injection per se did not
change the electrophysiological signature of the oocytes. The inward current most likely
occurred via the innate voltage-gated chloride channel in the oocytes [34–37].
The oocyte injected with mRNA encoding DM2–cMyc and that injected with PBS were
compared in terms of their electrophysiological behaviors using the TEVC method. The
DM2–cMyc-expressing oocytes showed an inward current of −3.0 μA at a membrane voltage
of −150 mV, whereas the PBS-injected oocyte showed an inward current of −0.2 μA (Fig 6A
and 6D). Thus, we interpreted that the inward current observed in DM2–cMyc RNA-injected
oocyte was due to the voltage-gated ion channel activity of the expressed protein. The charge
—voltage Boltzmann distribution model was applied to represent the gating voltage as the
midpoint of the sigmoid curve, Vmid (Table 1). The averaged tail Vmid values for DM2–cMyc-
injected oocyte and PBS-injected oocyte were −149 and −206 mV, respectively. During the
TEVC method, the DM2–cMyc-injected oocyte was more fragile than the PBS-injected oocyte,
Fig 4. Mass spectrometry and peptide identification. Presented the MS/MS fragmentation spectrum of the 36 amino acids peptide identified, Arg123 –Lys158. The
oocyte injected with RNA encoding DM2–cMyc was subjected to tryptic digestion followed by mass spectrometry using a nano-LC-MS/MS set-up. At 1255.91, a
peptide of 36-amino acid long which includes the C-terminal region, the linker, and a portion of the cMyc sequence (Fig 1) was confidently identified with m/z value.
The 20 and 17 successive peptide N-terminus retaining Y (blue) and peptide N-terminus retaining B fragment ions (red) matched the peptide sequence with a parent
ion mass error of 1.5 ppm. The identified amino acid sequence for Y peptide shown is backward (blue). The S1 Table shows the fragmentation table for the
corresponding peptide Arg123 –Lys158 representing both b- and y-ions.
https://doi.org/10.1371/journal.pone.0199227.g004
IDV M2
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and we often failed to clamp the membrane voltage. Taking these findings together, we
assumed that the same experimental procedure was applicable to other constructs, including
DM2 without a tag.
To test whether DM2 has ion channel activity, the TEVC method was used to observe the
voltage-gated current in oocytes injected with CM2- or DM2-encoding RNA (Fig 6A and 6B).
CM2 and DM2 mRNA-injected oocytes were also very fragile. Nevertheless, the CM2 con-
struct used in this study provided an induced inward current of −2.9 μA when the membrane
voltage was maintained at −130 mV (n = 5), which was consistent with the observation previ-
ously reported by Hongo et al. [25, 26]. The DM2 construct gave an inward induced current
of −3.5 μA at a membrane voltage of −130 mV. The Vmid values for CM2- and DM2-injected
oocytes were −122 and −127 mV, respectively.
To assess the ionic species passing through the DM2 ion channel, the reversal potential was
measured using two consecutive recordings. The first run was to monitor ion channel activity
Fig 5. Western blot analysis. One each of the uninjected and the DM2 cMyc RNA injected oocyte was subjected to
the Western Blot. The cMyc tag specific mouse monoclonal antibody 9E 10 was used to detect the expressed protein.
The protein size is given in kDa.
https://doi.org/10.1371/journal.pone.0199227.g005
IDV M2
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Fig 6. Induced current recorded by two-electrode voltage-clamp (TEVC) method at pH 8.5. A. Induced current
and given membrane potential. An oocyte injected with either RNA or phosphate-buffered saline was subjected to a
TEVC recording, and the current was measured for 2 s while the potential was kept constant at each of several
membrane potentials with 10 mV intervals. A relaxation time of 5 s was set before the next measurement while the
membrane was held at Vm = 0 mV. Short bars indicate values at -110 mV and the corresponding current for eye
IDV M2
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and activation of the ion channels; the second was to estimate the reversal potentials. The
reversal potentials for CM2 and DM2 were −22 and −21 mV, respectively (Table 2). The
valence of the ionic species was consistent with a pure Cl− permeability [38] when the
internal and external concentrations of chloride ions were 40 mM [39] and 103.6 mM (ND96),
respectively. When the sodium chloride in the ND96 solution was replaced by sodium metha-
nesulfonic acid [26], reversal potentials were reduced to −7 and −6 mV for CM2 and DM2,
respectively. For the DM2, the reversal potentials in reduced Na+ and increased K+ were -20
and -22 mV, respectively. To further assess the DM2 properties, a stilbene disulfonate chloride
channel inhibitor, 4,4’-diisothiocyano-2,2’stilbenedisulfonic acid (DIDS), was used [40].
Administration of 400 μM of DIDS reduced both activating and tail current at the holding
potential less than -110 mV (Fig 6A and 6C). The reversal potential of DM2 injected oocytes
was reduced from -21 mV to -16 (± 1) mV. In the PBS injected oocytes, the reversal potentials
were with and without DIDS, -21 (± 5)mV and -22 (± 5) mV, respectively. DM2 can be clari-
fied as a DIDS-sensitive ion channel. Taking these findings together, we concluded that DM2
exhibited chloride ion channel activity under the same conditions in which the CM2 ion chan-
nel activity was reproduced [26].
Key amino acids for the gating in DM2 protein
We hypothesized that the YxxxK sequence motif is involved in ion channel function in DM2
(Fig 1A and 1B). To confirm the roles of the motif, we prepared two variants of the motif,
AxxxK and YxxxA, by site-directed mutagenesis. The oocyte injected with mRNA of the
mutated constructs was more stable than that injected with DM2. The observed gating voltages
represented by tail Vmid for Y72A- and K76A-mutated DM2 were −109 and -129 mV, respec-
tively (Table 1; Fig 6A and 6E). Y72A-DM2 showed activating Vmid values different from that
of native DM2 (−127 mV). Mutated DM2, namely Y72A and K76A, showed similar reversal
potentials of −22 and −21 mV, respectively (Table 2). However, the replacement of chloride
ions in the ND96 solution caused the reversal potentials to differ between the two types of
mutated DM2. This suggested that the YxxxK motif is involved in the gating function.
references. B-E. Overlapping traces for activating and tail current vs. holding potential. An average of 5 measurements
were plotted with the SD. Solid bars indicate p<0.05 in the t-test. Cartoons represent the molecular organizations of
M2 proteins. The green circle and D represents DIDS.
https://doi.org/10.1371/journal.pone.0199227.g006
Table 1. Activating and tail Vmid
a values fitted by the charge–voltage Boltzmann distribution model (N = 5).
Oocyte Activating Vmid (mV) SD (mV) Tail Vmid (mV) SD (mV)
CM2 -141 ± 10 -122 ± 2
DM2 -139 ± 3 -127 ± 1
DM2 Y72A -103 ± 2 -109 ± 1
DM2 K76A -120 ± 3 -129 ± 1
DM2 cMyc -156 ± 11 -149 ± 1
DM2 RT -168 ± 4 -171 ± 1
PBS -203 ± 2 -206 ± 2
DM2 DIDS b -162 ± 3 -163 ± 4
PBS DIDS b -226 ± 2 -230 ± 3
a Mean simulated membrane potential that leaves half of ion channels open (Vmid) by the charge—voltage Boltzmann
distribution model. Correlation coefficient in the fitting of the Boltzmann curve was at least 0.90.
b Administrated DIDS at 400 μM.
https://doi.org/10.1371/journal.pone.0199227.t001
IDV M2
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The DM2–cMyc-injected oocyte showed more negative Vmid than the native DM2-injected
oocyte. Compared with native DM2, DM2–cMyc has extra 13 amino acids, including a spacer
and cMyc-tag, at its C-terminal (Fig 1C). We hypothesized that this extended C-terminal
affects the ion channel function. We constructed a DM2 variant with extra 16 amino acids at
the carboxyl end of DM2 (DM2 RT) to mimic the cMyc-tag. The tail Vmid value for DM2–RT-
injected oocyte was −171 mV, which was more negative than that for DM2–cMyc (Table 1; Fig
6A and 6D). Thus, additional amino acids at the carboxyl end probably alter channel function
(Fig 1C).
Discussion
The gating activity of M2 proteins involves amino acid side chains, namely through cation—pi
interactions [41]. In the channel activation of AM2, lowering the pH gradually opens the
Trp41 gate first, followed by a decrease in the deprotonation barrier of the His37 tetrad [21].
Trp41Ala substitution in AM2 was reported to result in the complete loss of ion channel activ-
ity [42]. In the case of CM2, which lacks Trp41 in AM2, Hongo et al. [25] reported a modest
acid activation. A change of pH from 8.5 to 5.5 increases the relative current by approximately
1.3-fold in CM2. In DM2, we recorded the induced current at pH 8.5, 6.5, and 5.5. Neverthe-
less, there weren’t significant change in the induced current.
In the case of the AM2 helical bundle, the linkage of neutral imidazole rings of four His37
residues and the physical blockage by bulky indole rings of Trp41 facilitate the closing of the
valve [43]. From protonation of the imidazole rings, the cation—pi interaction arises and the
channel eventually opens. In the DM2 helical bundle, there are four potential cation—pi pairs,
YxxxK. The average cation—pi interaction energy for the interacting pair Y-K was reported
-4.1 kcal/mol [44]. Using this value, the sum of the interaction energy was: (−4.1) × 4 = −16.4
kcal/mol. When we set the internal concentration of chloride ions as 40 mM [39], the free
energy change corresponding to Cl− transfer from inside to outside the cell [45] can be calcu-
lated by the sum of the ion concentration gradient and membrane electrical potential at −152
mV: ΔGc = RT ln(40/103.6) = −0.4 kcal/mol; ΔGm = FE = 96,500 (C/mol) x 0.152 (V) x 1.99
(kcal) / 8.314 kJ = −3.5 kcal/mol; ΔG = ΔGc + ΔGm = (−0.4) + (−3.5) = −3.9 kcal/mol. The
energy barrier by the YxxxK motif in terms of cation—pi interactions, −16.4 kcal/mol, is suffi-
ciently large to regulate the ion flow, −3.9 kcal/mol.
The reversal potentials of the ion channels (Table 2) suggested that DM2, Y72A, and K76A
conduct chloride ions as CM2 does, as their reversal potentials in ND96 solution (103.6 mM
Cl−) do not differ significantly. Namely, the mutant reversal potentials in chloride-substituted
ND96 (7.6 mM Cl−) are too different from those of CM2 and DM2 to suggest chloride specific-
ity. Where, ECl = 58 (mV) x log(7.6 mM /40 mM) = +42 mV. These results suggested that the
Table 2. Reversal potential (RP; N = 5).
M2 RP in ND96 (mV) RP in ND96 replaced Cl− (mV) a RP in ND96 replaced Na+ (mV) b in ND96 increased K+ (mV) c
DM2 −20.95 ± 1.05 −5.84 ± 0.40 −20.2 ± 0.31 −22.3 ± 7.1
DM2 Y72A −21.77 ± 0.77 −9.75 ± 1.97 N/T N/T
DM2 K76A −21.19 ± 1.34 −14.03 ± 2.34 N/T N/T
CM2 −22.05 ± 1.19 −6.52 ± 2.06 N/T N/T
a Reduced [Cl−] from 103.6 mM to 7.6 mM by replacing 96 mM NaCl in ND96 with 96 mM methane-sulfonic acid sodium salt.
b Reduced [Na+] from 96.4 mM to 0.1 mM by 96 mM NaCl in ND96 with 96 mM N-methyl-D-glucamine hydrochloride.
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mutations interfere with the ion channel, but the specific mechanism involved in this is yet to
be determined.
Nevertheless, the cation—pi interactions malfunction when either cation or pi-structure is
missing. In the case of DM2, in the YxxxK motif, Tyr and Lys are potentially charged nega-
tively and positively at pH 8.5, respectively. DM2 is likely to have a valve mechanism different
from that of AM2 because Tyr and Lys can potentially form both ionic and cation—pi interac-
tions [46, 47]. With DM2 Tyr72Ala, the pi provider was removed, so the amino acid remained
hydrophobic. In DM2 Lys76Ala, the cation was removed and a hydrophobic side chain was
introduced. Each step requires a certain amount of energy. In both types of mutated DM2,
the gating potential was decreased, although this decrease was greater in Y72A than in K76A
(Table 1). This suggested that Tyr72 provides a greater energy barrier than Lys76.
Although this report shows that DM2 functions as an ion channel, we continue to make
efforts to clarify the molecular mechanism underlying the regulation of ion flow and to eluci-
date the functional evolutionary pathway of the four M2 proteins.
Materials and methods
This research was performed under the supervision of the Institutional Biosafety Committee at
the University of Nebraska—Lincoln (Protocol Number 174).
Construction of plasmids and mRNA synthesis
A Xenopus oocyte expression vector, pNCB1 (GenBank accession number MF984401),
was constructed based on pGEMHE [32], which contains a T7 promoter, β-globin 50-UTR,
multiple cloning sites, β-globin 30-UTR, and a poly-A sequence. Native CM2 [Locus,
YP_089658.1 (C/Ann Arbor/1/50)] and native and modified DM2 [Locus, AFJ19025 ((D/
Swine/Oklahoma/1334/2011)] were synthesized by adding sequences corresponding to a
restriction enzyme site immediately before and after the coding sequence and were cloned
into pNCB1. BamHI and XbaI were used for 50 and 30 ends, except in the case of CM2 (SmaI
was used at the 50 end). DNA was prepared by GenScript (Piscataway, NJ, USA). Before
mRNA preparation, pNCB plasmid clones were linearized by HindIII and recovered by etha-
nol precipitation using half volume of 5 M ammonium acetate and two volumes of 100% eth-
anol. Invitrogen Ambion mMESSAGE mMACHINE T7 Transcription Kit (Thermo Fisher,
Waltham, MA, USA) was used for mRNA synthesis. mRNA was recovered by LiCl precipita-
tion and dissolved into PBS comprising 137 mM NaCl, 2.7 mM KCl, and 1.8 mM Na2HPO4.
mRNA was stored in −20˚C.
Injection of mRNA-containing oocyte
Pipettes were pulled with a pipette puller, P-97 (Sutter Instrument, Novato, CA, USA), to
set the tips at diameters of<22.5 μm and lengths of approximately 2.5 cm. Pipette tips were
inspected with Microforge MF-830 (Narishige International USA, East Meadow, NY, USA) to
ensure that they were smooth at the edges, so as not to tear the oocyte membrane, and to verify
that the diameter was acceptable. Defolliculated Xenopus oocytes were purchased from Xeno-
pus 1 (Dexter, MI, USA). Oocytes were injected using Auto-Nanoliter Injector Nanoject II
(Drummond Scientific, Broomall, PA, USA). Each oocyte was placed in ND96 pH 8.5 buffer
(96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES-NaOH) [26]
and injected with 50.6-nl mRNA. Other oocytes were injected with PBS to be considered as
controls.
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Immunofluorescent imaging
MYC Mouse Antibody 9E 10 (Developmental Studies Hybridoma Bank, University of Iowa,
Iowa City, IA, USA) was used to detect the cMyc-tag. Defolliculated oocytes injected with
cRNA or PBS and incubated for 5 days were fixed in 4% paraformaldehyde and blocked in 5%
horse serum in Tris-buffered saline (TBS) solution. The oocytes were incubated in 1:500 anti-
myc mouse antibody 9E10 diluted in 1% skim milk in TBS-T solution (TBS containing 0.05%
Tween-20) and were then incubated in 1:250 Alexa Fluor 488 donkey anti-mouse antibody
(Thermo Fisher) diluted in 1% skim milk in TBS-T solution. Oocytes were then observed
under the Olympus FV500 Confocal Microscope at the Morrison Microscopy Core Research
Facility at the Center for Biotechnology in the University of Nebraska—Lincoln (CBT UNL).
Mass spectrometry
An oocyte injected with RNA encoding cMyc-tagged DM2 was transferred to an Eppendorf
tube with an aliquot of ND96 medium. After the removal of the ND96 medium, 2-μg trypsin
in 200 μl of 50 mM NH4HCO3 in PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 10
mM KH2PO4) was added and was incubated at 25˚C. After 5 h, 5 μl of solution was sampled
and was run on a 0.075mm x 250mm C18 CSH column (Waters, Milford, MA, USA) by
nano-liquid chromatography coupled to tandem mass spectrometry (nano-LC-MS/MS) [48],
which is equipped with a Dionex RSLCnano U3000 and a Q-Exactive HF mass spectrometer
(Thermo Fisher). This oocyte kept the globular outer shape for over 10 h, whereas the oocyte
treated using trypsin with ND96 was disrupted in 10 min. Mascot (Matrix Science, London,
UK; version 2.5.1) was used to analyze all the MS/MS samples. Mascot was set up to search the
cRAP_20150130 (113 entries), the Uniprot of Xenopus laevis (June 2017, 42878 entries) data-
bases and a custom database containing the DM2–cMyc sequence. Trypsin was the digestion
enzyme. Mascot was searched with a fragment ion mass tolerance of 0.060 Da and a parent
ion tolerance of 10.0 PPM. The deamidation of asparagine and glutamine and the oxidation
of methionine were specified in Mascot as variable modifications. Scaffold (version Scaf-
fold_4.8.1; Proteome Software Inc., Portland, OR, USA) was used to validate the MS/MS-
based peptide and protein identifications. The identifications of peptide were accepted if they
could be established at a 1% false-discovery rate (FDR) by the Peptide Prophet algorithm with
Scaffold delta-mass correction [49]. This part of the work was performed by the Proteomics
and Metabolomics Facility at CBT UNL.
Western blot analysis
Western blot analysis. After 3 days of incubation in ND96, either intact or injected by DM2
cMyc RNA, oocytes were homogenized in 20 μL of HEPES buffer, pH 7.4, and centrifuged for
5 min at 800 x g at room temperature [50]. The proteins from 10 μL of each supernatant were
separated by sodium dodecyl sulfate polyacrylamide gel (20%) electrophoresis. Proteins were
transferred to a polyvinylidene fluoride membrane (0.2 μm pore size) that was blocked in Tris-
buffered saline (TBS) containing 5% nonfat milk. The blot was stained with mouse anti-cMyc
9E10 in 2% BSA, washed with 0.1% Tween in TBS, and stained with a goat anti-mouse horse
radish peroxidase conjugate in 5% nonfat milk in TBS. C-DiGit imager (LI-COR Biosciences,
Lincoln, Nebraska, USA) was used to acquire the enhanced chemiluminescence signal.
Electrophysiological recording
Glass electrodes (approximately 5 cm in length) were prepared by the P-97 puller. The tips
were approximately 3 mm long and22.5 μm in diameter. Each electrode was filled with 3 M
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filter-sterilized KCl and was placed on the voltage and current electrode holders of the Oocyte
Clamp Amplifier OC-725C (Warner Instruments, Hamden, CT, USA). The OC-725C ampli-
fier was connected to the Digidata 1550A Digitizer (Molecular Devices, Sunnyvale, CA, USA).
Each oocyte was placed in a bath containing pH 8.5 ND96. The bath electrodes were set,
and the voltage and current electrodes were used to puncture the oocyte. pCLAMP software
(Molecular Devices) was used to control the holding potential of the oocyte and to record the
resulting currents. The holding potential was decreased from 60 to −200 mV incrementally by
−10 mV for 2 s at each step. The measurements of CM2 ended at −130 mV, of DM2 at −160
mV, and the measurements of control ended at −200 mV, depending on the capability of
the clamping. The Boltzmann charge—voltage option in the pCLAMP program (Molecular
Devices) was used to perform the data analysis [38, 51]. Where the Boltzmann Model is
given: f (V) = Imax (1 + exp((Vmid − V)/VC) + C, where V, membrane potential; Imax, maximal
current; Vmid, membrane potential when current is half-maximal; VC, voltage required to
change I e-fold; C: constant y-offset. Curve fitting was performed using activating current at 2
s and tail current at 2.3 s. The membrane potential that resulted in half the maximal opening
of the ion channels (Vmid) was obtained as one of the representative values. The Nernst
Potential Calculator was used to calculate the equilibrium potential (PhysiologyWeb at www.
physiologyweb).
Structural informatics
The prediction of transmembrane domains was performed using TMHMM [52]. The second-
ary structure was predicted using the Jpred server [53]. The isoelectric points and hydropho-
bicity represented by the GRAVY parameter were calculated using the ProtParam tool [54].
Prediction of glycosylation was performed using NetNGlyc 1.0 Server (www.cbs.dtu.dk/
services/NetNGlyc/). The structural model for DM2 was compiled using the NMR structure of
AM2 [23] as a template on the SWISS-MODEL server [55]. Graphics were prepared using the
PyMOL Molecular Graphics System, Version 1.8 (Schro¨dinger, LLC, New York, NY, USA).
Supporting information
S1 Table. The fragmentation table for the corresponding the peptide Arg123-Lys158 repre-
senting both B- and Y-ions.
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